Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBB vs. IBBQ: which is better?

Bottom line

IBB vs IBBQ: the short answer

IBB (iShares Biotechnology ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) share a meaningful slice of their top holdings — about 56% by weight.

IBBQ is cheaper at 0.19% vs 0.44% — a difference of $25 a year per $10,000 invested.

Over one year, IBB returned +28.0% vs −0.6% for IBBQ (reporting dates differ).

Updated Nov 19, 2026

IBB vs IBBQ side by side

IBBIBBQ
TypeETFETF
Fund familyiSharesInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio0.44%0.19%
Annual cost per $10k$44$19
10-yr cost on $10k (prospectus)$555$242
Max front loadNoneNone
12b-1 fee0%—
1-yr return+28.0%−0.6%
5-yr return (annualized)+2.5%—
10-yr return (annualized)+4.4%—
Best quarter+26.8%+12.0%
Worst quarter−22.9%−11.7%
Net assets (fund)$5.9B$67.4M
Number of holdings254261
Portfolio turnover27%17%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBIBBQDifference
2024−2.4%−0.6%−1.8%
2023+3.6%+4.5%−0.9%
2022−13.6%−10.2%−3.3%

Source: Fund prospectus bar charts

Holdings overlap

14 of IBB's top 25 holdings also appear in IBBQ's top 25.

Shared top holdings
HoldingIBBIBBQ
Vertex Pharmaceuticals, Inc.7.66%7.38%
Gilead Sciences, Inc.7.52%7.39%
Amgen, Inc.7.50%7.10%
Regeneron Pharmaceuticals, Inc.5.70%5.08%
Alnylam Pharmaceuticals, Inc.5.68%3.19%
Argenx SE3.15%1.89%
Insmed, Inc.2.95%1.83%
Biogen, Inc.2.03%2.29%
United Therapeutics Corp.1.82%1.94%
Incyte Corp.1.62%1.53%
Illumina, Inc.1.41%1.98%
Neurocrine Biosciences, Inc.1.34%1.26%
Exelixis, Inc.1.07%1.04%
Moderna, Inc.0.88%1.48%

Source: SEC Form N-PORT

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

IBBQ top 10

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Vertex Pharmaceuticals Inc. — 7.38%
  4. Amgen Inc. — 7.10%
  5. Invesco Private Government Fund — 5.48%
  6. Regeneron Pharmaceuticals, Inc. — 5.08%
  7. Alnylam Pharmaceuticals, Inc. — 3.19%
  8. Revolution Medicines, Inc. — 2.48%
  9. Biogen Inc. — 2.29%
  10. Illumina, Inc. — 1.98%

FAQ

What is the difference between IBB and IBBQ?
IBB (iShares Biotechnology ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) share a meaningful slice of their top holdings — about 56% by weight. IBBQ is cheaper at 0.19% vs 0.44% — a difference of $25 a year per $10,000 invested.
Which is cheaper, IBB or IBBQ?
IBBQ has the lower expense ratio (0.19%).
Should I own both IBB and IBBQ?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.